Expanding the Comprehensive Unit-based Safety Program (CUSP) to reduceCentral Line-Associated Blood Stream Infections (CLABSI) and Catheter-Associated Urinary Tract Infections (CAUTI) in Intensive Ca
Expanding the Comprehensive
Unit-based Safety Program (CUSP) to reduceCentral Line-Associated
Blood Stream Infections (CLABSI) and Catheter-Associated Urinary
Tract Infections (CAUTI) in Intensive Ca
New
collection (Request for a new OMB Control Number)
DHHS Action Plan to Prevent
Healthcare-Associated Infections In January 2009, the Department of
Health and Human Services (HHS) released the first iteration of the
National Action Plan to Prevent Healthcare-Associated Infections
(HAI NAP). The HAI NAP was developed by the HHS Office of Public
Health and Science, AHRQ, Centers for Disease Control and
Prevention (CDC), Centers for Medicare & Medicaid Services
(CMS), and other offices and operating divisions of HHS. As part of
the Department of Health and Human Services (DHHS) National Action
Plan (NAP) to Prevent Healthcare-Associated Infections (HAI), AHRQ
has supported the implementation and adoption of the Comprehensive
Unit-based Safety Program (CUSP) to reduce Central-Line Associated
Bloodstream Infections (CLABSI) and Catheter-Associated Urinary
Tract Infections (CAUTI), and is applying the principles and
concepts that have been learned from these HAI reduction efforts to
ICUs with persistently elevated infection rates. Results of
Implementation of CUSP for CLABSI and CAUTI The nationwide CUSP for
CLABSI project implemented CUSP with ICU teams at more than 1,100
adult ICUs in 44 states over a 4-year period. ICUs participating in
this project reduced the rate of CLABSIs nationally from 1.915
infections per 1,000 central line days to 1.133 infections per
1,000 line days, an overall reduction of 41 percent. However, not
all ICUs performed equally well. The CUSP for CAUTI project
implemented CUSP in nine cohorts, representing over 1,600 hospital
units in over 1,200 hospitals located across 40 states, the
District of Columbia, and Puerto Rico. Inpatient CAUTI rates in
non-ICUs were decreased by 30%. However, CAUTI rates in ICUs were
not reduced significantly. In other words, while the overall
results of the implementation of CUSP for CLABSI and CUSP for CAUTI
have shown remarkable progress, not all ICUs in the projects have
achieved the intended rate reductions, nor have all ICUs
participated in the two projects. Moreover, a significant number of
institutions and ICUs continue to have persistently elevated
infection rates. There are institutions that have varying rates of
infections within the same institution indicating that infection
control is often a unit-based issue. In sum, despite the
significant overall reductions in CLABSI and CAUTI rates that have
been achieved in these two projects, there is evidence that ICUs
have generally faced challenges in reducing CAUTI rates, and that
many hospitals still are not where they should be in CLABSI rates.
Modified approaches and strategies for the CUSP intervention need
to be developed and implemented to reach ICUs with persistently
elevated CLABSI and CAUTI rates and help them succeed in preventing
these infections. To address this need, AHRQ will launch this
project aimed at spreading nationally implementation of an
adaptation of CUSP for CLABSI and CAUTI for ICUs with persistently
elevated rates, optimizing the approach to maximize effectiveness,
and further preventing these infections throughout the United
States. This project has the following goals: • Reduce central
line-associated bloodstream infections (CLABSI) and
catheter-associated urinary tract infections (CAUTI) in ICUs with
persistently elevated rates. • Revise and augment current CUSP
training resources and materials for CUSP for CLABSI and CAUTI in
ICUs with persistently elevated rates. The resulting toolkit will
be intended for use in ICUs whose infection rates for either or
both of these HAIs are persistently elevated compared to other
ICUs. • Recruit 450-600 ICUs with persistently elevated rates
nationally to demonstrate the utility of applying a modified CUSP
for CLABSI and CUSP for CAUTI during the performance period to
reduce rates of CLABSI and CAUTI in these ICUs. • Assess the
adoption of the modified CUSP for CLABSI and CAUTI and evaluate the
effectiveness of the intervention in the participating
ICUs
US Code:
42
USC 299 Name of Law: Agency for Healthcare Research and Quality
Act 1999
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.